HOME Research Directors, Research Projects Adopted FY2012 : Takanori Yokota
Development for molecular technology
with new class of nucleotide drug
In order to achieve “healthy and productive senescence” in rapidly aged society, we develop our new class nucleotide drug to overcome difficult disorders including Alzheimer disease by cross-sectoral approach of medicine, pharmacology and engineering in this project. Then, we hope to open a new horizon in drug-discovery with this cardinal molecular technology of Japan and make an international contribution by producing safe and orally intaken heroic drugs for these incurable diseases.